Cargando…

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer

BACKGROUND: Significant clinical heterogeneity within contemporary risk group is well known, particularly for those with intermediate-risk prostate cancer (IRPCa). Our study aimed to analyze the ability of the Cancer of the Prostate Risk Assessment (CAPRA) score to discern between favorable and non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Ho Won, Jung, Hae Do, Lee, Joo Yong, Kwon, Jong Kyou, Jeh, Seong Uk, Cho, Kang Su, Ham, Won Sik, Choi, Young Deuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773849/ https://www.ncbi.nlm.nih.gov/pubmed/29349945 http://dx.doi.org/10.3346/jkms.2018.33.e36

Ejemplares similares

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols
por: Kang, Ho Won, et al.
Publicado: (2015)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
por: Kang, Yong Jin, et al.
Publicado: (2017)

Intraoperative and postoperative feasibility and safety of total tubeless, tubeless, small-bore tube, and standard percutaneous nephrolithotomy: a systematic review and network meta-analysis of 16 randomized controlled trials
por: Lee, Joo Yong, et al.
Publicado: (2017)

Association of Anterior and Lateral Extraprostatic Extensions with Base-Positive Resection Margins in Prostate Cancer
por: Kang, Yong Jin, et al.
Publicado: (2016)

Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
por: Park, Jae Won, et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of Functional Outcomes and Complications Following the Photoselective Vaporization of the Prostate and Monopolar Transurethral Resection of the Prostate
por: Kang, Dong Hyuk, et al.
Publicado: (2016)

Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
por: Han, Hyunho, et al.
Publicado: (2022)

Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis
por: Kang, Dong Hyuk, et al.
Publicado: (2016)

Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
por: Park, Jae Won, et al.
Publicado: (2018)

The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer
por: Jang, Won Sik, et al.
Publicado: (2016)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Effects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia
por: Choi, Jae Hwi, et al.
Publicado: (2014)

Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
por: Han, Hyunho, et al.
Publicado: (2021)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
por: Lee, Hye Won, et al.
Publicado: (2015)

No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
por: Cyll, Karolina, et al.
Publicado: (2022)

Predictive factors and treatment outcomes of Steinstrasse following shock wave lithotripsy for ureteral calculi: A Bayesian regression model analysis
por: Kang, Ho Won, et al.
Publicado: (2018)

A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging
por: Lee, Joo Yong, et al.
Publicado: (2015)

Is a Decreased Serum Testosterone Level a Risk Factor for Prostate Cancer? A Cohort Study of Korean Men
por: Shin, Bo Sung, et al.
Publicado: (2010)

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
por: Drachenberg, Darrel, et al.
Publicado: (2019)

MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Krishnananthan, Nishanth, et al.
Publicado: (2016)

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
por: Helfand, Brian T., et al.
Publicado: (2022)

Optimal Skin-to-Stone Distance Is a Positive Predictor for Successful Outcomes in Upper Ureter Calculi following Extracorporeal Shock Wave Lithotripsy: A Bayesian Model Averaging Approach
por: Cho, Kang Su, et al.
Publicado: (2015)

Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
por: Leapman, Michael S., et al.
Publicado: (2017)

Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer
por: Lee, Joo Yong, et al.
Publicado: (2014)

Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men
por: Moustsen, Ida Rask, et al.
Publicado: (2019)

Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
por: Park, Cheol Keun, et al.
Publicado: (2021)

Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
por: Heo, Ji Eun, et al.
Publicado: (2019)

Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer
por: Lee, Jongsoo, et al.
Publicado: (2020)

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy
por: Agrawal, Vishesh, et al.
Publicado: (2022)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Are More Low-Risk Prostate Cancers Detected by Repeated Biopsy? A Retrospective Pilot Study
por: Lee, Seung Je, et al.
Publicado: (2013)

Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study
por: Hwang, Insang, et al.
Publicado: (2015)

Optimal Baseline Prostate-Specific Antigen Level to Distinguish Risk of Prostate Cancer in Healthy Men Between 40 and 69 Years of Age
por: Park, Kyung Kgi, et al.
Publicado: (2012)

Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
por: Jeong, Bae-Kwon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vn5im8nnb4k8he4no9cd88lbq8